3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
6
NIH
1
NETWORK
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Central Nervous System Neoplasms
38
Head and Neck Neoplasms
32
Lung Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
28
Lymphoma
27
Carcinoma, Non-Small-Cell Lung
23
Prostatic Neoplasms
21
Breast Neoplasms
18
Brain Neoplasms
18
Leukemia
15
Glioblastoma
15
Sarcoma
13
Gliosarcoma
13
Uterine Cervical Neoplasms
12
Astrocytoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Adenocarcinoma of Lung
11
Burkitt Lymphoma
10
Rhabdomyosarcoma
9
Neoplasm Metastasis
9
Lymphoma, Large B-Cell, Diffuse
9
Hodgkin Disease
9
Rectal Neoplasms
8
Radiation Injuries
8
Oligodendroglioma
8
Esophageal Neoplasms
8
Colorectal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Urinary Bladder Neoplasms
6
Stomach Neoplasms
6
Interventions
Ifosfamide
5
Doxorubicin
4
Specimen Handling
3
Methotrexate
3
Etoposide
3
Cisplatin
3
Sorafenib
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
sodium thiosulfate
1
sargramostim
1
pepinemab
1
peginterferon alfa-2b
1
mifamurtide
1
merphos
1
lorukafusp alfa
1
irinotecan sucrosofate
1
imetelstat
1
etoposide phosphate
1
Zoledronic Acid
1
X-Rays
1
Thrombopoietin
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Razoxane
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Osteosarcoma
×
Radiotherapy
×
Clear all
NCT04890067
2026-03-27
ISG Os2Oss
Italian Sarcoma Group
Recruiting
120 enrolled